nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia
|
Fantino, Manon |
|
|
15 |
4 |
p. 602-607 |
artikel |
2 |
Carotid sheath xanthoma: A rare manifestation of lipid disorders
|
Gao, Binyang |
|
|
15 |
4 |
p. 574-578 |
artikel |
3 |
Cerebrotendinous xanthomatosis, sitosterolemia, Smith-Lemli-Opitz syndrome and the seminal contributions of Gerald Salen, MD (1935–2020)
|
Schaefer, Ernst J. |
|
|
15 |
4 |
p. 540-544 |
artikel |
4 |
Early use of PCSK9 inhibitor therapy after heart transplantation from a hepatitis C virus positive donor
|
Fanous, Matthew M. |
|
|
15 |
4 |
p. 579-583 |
artikel |
5 |
Editorial Board
|
|
|
|
15 |
4 |
p. A1-A3 |
artikel |
6 |
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience
|
Alonso, Rodrigo |
|
|
15 |
4 |
p. 584-592 |
artikel |
7 |
Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)
|
Nomura, Sarah O. |
|
|
15 |
4 |
p. 608-617 |
artikel |
8 |
From the editor: Prevention then and now
|
Guyton, John R. |
|
|
15 |
4 |
p. 527 |
artikel |
9 |
From the President of the International Atherosclerosis Society: The Iraqi Lipid Clinics Network
|
Al-Khnifsawi, Mutaz |
|
|
15 |
4 |
p. 538-539 |
artikel |
10 |
JCL Roundtable. Making prevention a priority
|
Agarwala, Anandita |
|
|
15 |
4 |
p. 530-537 |
artikel |
11 |
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial
|
Rubino, John |
|
|
15 |
4 |
p. 593-601 |
artikel |
12 |
News from the NLA
|
|
|
|
15 |
4 |
p. 528-529 |
artikel |
13 |
Normal plasma apoB48 despite the virtual absence of apoB100 in a compound heterozygote with novel mutations in the MTTP gene
|
Takahashi, Manabu |
|
|
15 |
4 |
p. 569-573 |
artikel |
14 |
Table of Contents
|
|
|
|
15 |
4 |
p. A4-A5 |
artikel |
15 |
Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction
|
Liu, Qiyuan Keith |
|
|
15 |
4 |
p. 556-568 |
artikel |
16 |
Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention
|
Kapoor, Karan |
|
|
15 |
4 |
p. 545-555 |
artikel |